SOPHiA GENETICS to Participate in Upcoming November Investor Conferences

Rhea-AI Summary

SOPHiA GENETICS (Nasdaq: SOPH) announced its participation in two upcoming investor conferences. The company will hold a fireside chat at the Evercore ISI HealthCONx Virtual Conference on November 29 at 2:15 PM EST and at the Credit Suisse 26th Annual Technology Conference on November 30 at 1:40 PM MST. Live and archived webcasts can be accessed through the Investor Relations section of their website. SOPHiA GENETICS focuses on data-driven medicine through its SOPHiA DDM™ Platform, serving numerous healthcare institutions globally.

BOSTON and LAUSANNE, Switzerland, Nov. 04, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, announced today the company will be participating in the following investor conferences.

• Evercore ISI HealthCONx Virtual Conference; Fireside Chat on Tuesday, November 29 at 2:15pm EST / 8:15pm CET
  
  
• Credit Suisse 26^th Annual Technology Conference in Scottsdale, AZ; Fireside Chat on Wednesday, November 30 at 1:40pm MST / 9:40pm CET

Interested parties may access live and archived webcasts of the sessions on the Investor Relations section of the company website at ir.sophiagenetics.com.

About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a software company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-native platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by a broad network of hospital, laboratory, and biopharma institutions globally. For more information, visit SOPHiAGENETICS.COM, or connect on Twitter, LinkedIn, Facebook, and Instagram. Where others see data, we see answers.

Investor Contact:
Jennifer Pottage
Head of Investor Relations
ir@sophiagenetics.com

Media Contact:
Kelly Katapodis
Senior Manager, Media & Communications
media@sophiagenetics.com

FAQ

What is the date of SOPHiA GENETICS' participation in the Evercore ISI HealthCONx Virtual Conference?

SOPHiA GENETICS will participate in the Evercore ISI HealthCONx Virtual Conference on November 29, 2022.

When will SOPHiA GENETICS present at the Credit Suisse Annual Technology Conference?

The presentation at the Credit Suisse 26th Annual Technology Conference is scheduled for November 30, 2022.

How can I access the webcasts of SOPHiA GENETICS' investor conferences?

Live and archived webcasts of SOPHiA GENETICS' investor conferences can be accessed on their Investor Relations website.

What platform does SOPHiA GENETICS use for data analysis?

SOPHiA GENETICS utilizes its SOPHiA DDM™ Platform for analyzing complex multimodal data.

What sectors does SOPHiA GENETICS serve?

SOPHiA GENETICS serves hospitals, laboratories, and biopharma institutions worldwide.